全球微生物发酵技术市场规模（按产品类型、应用、地区、范围和预测）

微生物发酵技术的市场规模及预测

预计微生物发酵技术市场规模在 2024 年将达到 305.6 亿美元，到 2032 年将达到 451.4 亿美元，2026 年至 2032 年的复合年增长率为 5%。

微生物发酵技术是指在特定环境条件下控制细菌、酵母和真菌等微生物的生长发育，从而生产有价值的产品。它利用微生物的代谢能力，透过生化反应将原料转化为所需的分子。发酵可以在有氧（有氧）或厌氧（无氧）条件下进行，这取决于微生物种类和预期结果。该技术最初用于食品和饮料生产，但后来扩展到药品、化学品、生质燃料，甚至生物分解性塑胶。

发酵法广泛应用于各行各业。它在优格、起司和麵包等发酵食品的生产中发挥着重要作用。在製药业，它用于生产抗生素、疫苗和治疗性蛋白质。在化学工业中，发酵产生的有机酸、酵素和胺基酸可用于各种产品。

微生物发酵市场显着扩张与创新。基因工程和合成生物学的进步正在提高微生物菌株的进化能力，并使其针对特定产品进行最佳化，从而提高产量和效率。永续实践和向循环经济的转变预计将推动微生物发酵领域的进一步研发，尤其是在生物基产品和再生能源来源。

微生物发酵技术的全球市场动态

影响全球微生物发酵技术市场的关键市场动态

关键市场驱动因素

生物基产品需求不断增长微生物发酵技术市场的发展受到客户对永续和天然产品日益增长的需求的推动。根据美国农业部的报告，预计到2024年，全球生物基产品市场规模将达到4,872亿美元。

食品和饮料行业的应用日益广泛：微生物发酵在食品和饮料行业被广泛采用，尤其是在益生菌和发酵食品的生产中。国际益生菌协会预测，到2023年，全球益生菌市场规模将达到693亿美元，2018年至2023年的复合年增长率为7.0%。

製药业应用不断扩展：微生物发酵正越来越多地用于生产抗生素和酵素等药物。根据世界卫生组织 (WHO) 的数据，预计到 2025 年，全球抗生素产业的价值将达到 503.7 亿美元，其中发酵技术将占产量的很大一部分。

主要挑战

製程优化与规模化生产的主要挑战之一是优化发酵操作，以实现最佳的生产力、纯度和效率。从实验室规模生产到工业规模生产，通常需要克服许多技术挑战，例如维持稳定的环境条件、确保无菌、控制发酵动力学。原料和微生物菌株的变异性也会阻碍规模化生产，需要投入大量的研发资金。

产品多样化和市场需求：满足市场对新产品和新应用的不同需求需要持续创新和适应性。微生物发酵技术必须跟上不断变化的客户需求、科学进步和环境目标。开发新的微生物菌株、根据特定产品客製化发酵条件以及展现出优于传统替代品的卓越性能，这些都是提升市场相关性和竞争力的持续挑战。

技术整合与数位化：将发酵製程与自动化、人工智慧和巨量资料分析等数位技术结合，既带来了机会，也带来了挑战。数位化可以改善製程控制、提高效率并提升产品质量，但成功整合这些技术需要在基础设施、经验和资料管理能力方面进行大量投资。

主要趋势：

生物製药的扩展：微生物发酵越来越多地用于生产抗体、疫苗和治疗性蛋白质等生物製药。基因工程和生物製程优化的进步使得能够以更高的产量和更低的价格生产复合化合物，从而促进了微生物发酵在生物製药领域的应用。

永续生物基产品的兴起：环境永续性意识的不断增强，推动市场朝向生物基产品迈进。微生物发酵透过将可再生原料转化为生物分解性的聚合物、生质燃料和绿色化学品，为标准化学合成过程提供了永续的替代方案。消费者对环保产品的偏好以及鼓励生物经济发展的监管奖励推动了这一趋势。

应用多样化：微生物发酵正在食品和製药等成熟产业之外寻找新的应用。农业、化妆品、纺织和生质能源产业越来越依赖微生物发酵来生产酵素、偏好、香料、生物农药和生物肥料。这种多样性源于微生物发酵的多功能性以及根据工业需求量身定制产品的能力。

目录

第一章全球微生物发酵技术市场介绍

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章 微生物发酵技术全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章 全球微生物发酵技术市场依产品类型划分

• 概述
• 酵素
• 抗生素
• 有机酸
• 维他命
• 生物聚合物

第六章 全球微生物发酵技术市场（依应用）

• 概述
• 製药
• 饮食
• 农业
• 工业化学品
• 环境保护

第七章 全球微生物发酵技术市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第八章全球微生物发酵技术市场竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第九章 公司简介

• F. Hoffmann-La Roche AG
• Koninklijke DSM NV
• Lonza Group AG
• Novozymes A/S
• Danone Ltd.
• Amyris, Inc.
• Biocon Ltd.
• TerraVia Holdings, Inc.
• BioVectra Inc
• United Breweries Ltd

第十章 附录

• 相关调查

Microbial Fermentation Technology Market Size And Forecast

Microbial Fermentation Technology Market size was valued at USD 30.56 Billion in 2024 and is projected to reach USD 45.14 Billion by 2032, growing at a CAGR of 5% from 2026 to 2032.

Microbial fermentation technology is the controlled development of microorganisms such as bacteria, yeast, or fungi under specified environmental conditions to produce valuable goods. It uses the metabolic capabilities of these microorganisms to convert raw materials into desired molecules using biochemical reactions. Fermentation can take place in either aerobic (with oxygen) or anaerobic (without oxygen) conditions, depending on the microbe and desired result. This technology was originally utilized for food and beverage production, but it has since grown to include medications, chemicals, biofuels, and even biodegradable plastics.

This method is used extensively in a variety of industries. It plays an important role in the manufacture of fermented foods such as yogurt, cheese, and bread. In the pharmaceutical industry, it is used to create antibiotics, vaccines, and therapeutic proteins. Fermentation in the chemical industry yields organic acids, enzymes, and amino acids, which are employed in a variety of products.

Significant expansion and innovation in the microbial fermentation market. Advances in genetic engineering and synthetic biology are improving our ability to evolve and optimize microbial strains for specific products, hence increasing production and efficiency. The transition to sustainable practices and the circular economy is expected to spur additional research and development in microbial fermentation, particularly for bio-based products and renewable energy sources.

Global Microbial Fermentation Technology Market Dynamics

The key market dynamics that are shaping the global microbial fermentation technology market include:

Key Market Drivers:

Growing Demand for Bio-Based Products: The market for microbial fermentation technology is being driven by rising customer demand for sustainable and natural products. According to a US Department of Agriculture report, the global biobased goods market is predicted to reach $487.2 billion by 2024.

Rising Adoption in the Food and Beverage Industry: Microbial fermentation is widely employed in the food and beverage industry, particularly for the manufacture of probiotics and fermented meals. The International Probiotics Association predicts that the global probiotics market will reach $69.3 billion by 2023, expanding at a 7.0% CAGR between 2018 and 2023.

Expanding Applications in the Pharmaceutical Industry: Microbial fermentation is increasingly being used to produce medications such as antibiotics and enzymes. According to the World Health Organization, the worldwide antibiotics industry is expected to be worth $50.37 billion by 2025, with fermentation technologies accounting for a considerable share of output.

Key Challenges:

Process Optimization and Scale-up: One of the main issues is optimizing fermentation operations for optimal productivity, purity, and efficiency. Scaling up production from laboratory to industrial sizes frequently necessitates solving technical challenges such as maintaining stable ambient conditions, assuring sterility, and controlling fermentation kinetics. Variability in raw materials and microbial strains can also hamper scaling efforts, necessitating significant R&D costs.

Product Diversification and Market Demand: Meeting different market needs for new products and applications necessitates ongoing innovation and adaptability. Microbial fermentation technology must keep up with changing customer demands, scientific improvements, and environmental aims. Developing new microbial strains, adjusting fermentation conditions for specific products, and demonstrating superior performance relative to traditional alternatives are all continuous difficulties for market relevance and competitiveness.

Technological Integration and Digitalization: Integrating fermentation processes with digital technologies like automation, artificial intelligence, and big data analytics creates both potential and obstacles. While digitalization can improve process control, efficiency, and product quality, successfully integrating these technologies necessitates significant investment in infrastructure, experience, and data management capabilities.

Key Trends:

Expansion in Biopharmaceuticals: Microbial fermentation is increasingly being used to produce biopharmaceuticals such as antibodies, vaccines, and therapeutic proteins. Advances in genetic engineering and bioprocess optimization allow for the manufacture of complex compounds with higher yields and lower prices, which is boosting the use of microbial fermentation in the biopharmaceutical sector.

Rise of Sustainable and Bio-Based Products: The growing awareness of environmental sustainability is propelling the market toward bio-based products. Microbial fermentation provides a sustainable alternative to standard chemical synthesis processes by converting renewable feedstocks into biodegradable polymers, biofuels, and green chemicals. Consumer preferences for environmentally friendly products, as well as regulatory incentives to promote bioeconomy development, are driving this trend.

Application Diversification: Microbial fermentation is finding new uses outside of established industries like food and pharmaceuticals. Agriculture, cosmetics, textiles, and bioenergy industries are increasingly relying on microbial fermentation to produce enzymes, tastes, perfumes, biopesticides, and biofertilizers. This diversity is fueled by the versatility of microbial fermentation and its capacity to tailor products to suit industrial requirements.

Global Microbial Fermentation Technology Market Regional Analysis

Here is a more detailed regional analysis of the global microbial fermentation technology market:

Asia Pacific:

The Asia Pacific region currently holds the crown for the microbial fermentation technology market. According to UNESCAP, the Asia Pacific region's population is expected to expand rapidly, reaching 4.7 billion by 2050, producing strong demand across a variety of sectors that rely on fermentation technologies. The food and beverage market are primed for tremendous growth.

The region's huge and growing population has resulted in an increase in demand for food and drinks, pharmaceuticals, and industrial enzymes, all of which rely heavily on fermentation.

A growing number of Asian countries are developing as hubs for biopharmaceutical outsourcing, drawing both domestic and foreign firms. This, together with rising disposable income and greater investment in the food and beverage industry, drives the demand for sophisticated fermentation technology.

North America:

North America is expected to be the fastest expanding market for microbial fermentation technologies. North America is seeing a tremendous movement toward sustainable and environmentally friendly products, which is boosting the development of microbial fermentation technological advances. The US Department of Agriculture's bio-preferred program emphasizes the bio-based goods sector's significant economic impact, which contributed $459 billion to the US economy in 2016 and continues to grow.

The National Research Council of Canada predicts that the global market for bio-based chemicals will reach $85.6 billion by 2024, with North America serving as a key driver of this expansion. The findings highlight the region's vital function in developing bio-based solutions using microbial fermentation technologies.

North America leads the way in incorporating precise fermentation processes into food technology. According to the Good Food Institute, North American firms focused on fermentation-enabled alternative proteins raised $1.7 billion in funding in 2021.

The United States Department of Agriculture predicts that by 2030, the global market for alternative proteins, including those obtained from fermentation, will account for 10% of the entire protein industry, representing a $14 billion opportunity. These advancements emphasize North America's critical role in developing the use of precision fermentation to create sustainable and innovative food solutions.

Global Microbial Fermentation Technology Market: Segmentation Analysis

The Global Microbial Fermentation Technology Market is Segmented on the basis of Product Type, Application, And Geography.

Microbial Fermentation Technology Market Segmentation Analysis

Microbial Fermentation Technology Market, By Product Type

• Enzymes
• Antibiotics
• Organic Acids
• Vitamins
• Biopolymer

Based on Product Type, the market is bifurcated into Enzymes, Antibiotics, Organic Acids, Vitamins, and Biopolymers. Antibiotics dominate the microbial fermentation technology market due to established manufacturing methods and strong demand for these life-saving medications. However, the biopolymers segment is predicted to develop the fastest, owing to the growing emphasis on sustainability and the demand for environmentally acceptable alternatives to standard plastics.

Microbial Fermentation Technology Market, By Application

• Pharmaceuticals
• Food & Beverages
• Agriculture
• Industrial Chemicals
• Environmental

Based on Application, the market is segmented into Pharmaceuticals, Food & Beverages, Agriculture, Industrial Chemicals, and Environmental. Due to the increasing demand for biopharmaceuticals such as antibiotics, vaccines, and other therapeutic proteins, the pharmaceutical segment now controls the majority of the microbial fermentation industry. However, the food and beverage industry is predicted to grow the fastest, thanks to the increased popularity of fermented goods such as yogurt and kombucha, as well as plant-based alternatives to meat and dairy.

Key Players

The "Global Microbial Fermentation Technology Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are F. Hoffmann-La Roche AG, Koninklijke DSM NV, Lonza Group AG, Novozymes A/S, Danone Ltd., Amyris, Inc., Biocon Ltd., TerraVia Holdings, Inc., BioVectra, Inc., and United Breweries Ltd. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Microbial Fermentation Technology Market Recent Developments
• In May 2023, Danone Manifesto Ventures invested in Imagindairy, an Israeli start-up. Thus, the corporation purchased a minority investment in the precision fermentation company.
• In January 2023, BioZyme announced the launching of AO-Biotics. AO, a strain known for its great robustness, is used in the fermentation process by the company to create new fermentation products.
• In September 2022, Genetica, Cargill, and Cyclone Engineers partnered on a project to increase bioreactor fermentation capacity. The National Biotechnology and Biomanufacturing Initiative funded this research with USD 2.5 million.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Enzymes
• 5.3 Antibiotics
• 5.4 Organic Acids
• 5.5 Vitamins
• 5.6 Biopolymer

6 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Pharmaceuticals
• 6.3 Food & Beverages
• 6.4 Agriculture
• 6.5 Industrial Chemicals
• 6.6 Environmental

7 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 F. Hoffmann-La Roche AG
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Koninklijke DSM NV
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Lonza Group AG
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Novozymes A/S
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Danone Ltd.
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Amyris, Inc.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Biocon Ltd.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 TerraVia Holdings, Inc.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 BioVectra Inc
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 United Breweries Ltd
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research